GPs in Northern Ireland will not implement NICE guidance unless resourced

24 March 2010

Usually it is drugmakers which argue against recommendations from the UK's National Institute for Health and Clinical Excellence (NICE), but his time its doctors. General Practitioners in Northern Ireland have backed calls for GPC Northern Ireland (GPCNI) to agree only to implement NICE guidance accompanied by adequate resources, reports HealthCare Republic.

Eastern LMC member Martin Cunningham told the Northern Ireland LMCs conference in Enniskillen over the weekend that, although the NICE vetoed expensive treatments, it often issued guidance with 'scant regard' to the cost of implementing it.

'This is a timely issue. We've heard that 65% of GPs rarely have access to psychological therapies within six months. It's an example of where the resources do not meet the guidelines,' he said, adding: 'Ultimately the result will be more articles in the press saying we have failed again.' A motion was passed calling for the GPCNI not to accept the implementation of 'any guidance or scenario' unless adequate resources were secured and 'a shared care plan is in place.'

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight





More Features in Pharmaceutical